Serum vascular endothelial growth factor predicts venous invasion in hepatocellular carcinoma: A prospective study

Annals of Surgery

Volumn 233, Issue 2, 2001, Pages 227-235

  Poon, Ronnie Tung Ping ^a,b   Ng, Irene Oi Lin ^a   Lau, Cecilia ^a   Zhu, Li Xin ^a   Yu, Wan Ching ^a   Lo, Chung Mau ^a   Fan, Sheung Tat ^a   Wong, John ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b QUEEN MARY HOSPITAL   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR MARKER; VASCULOTROPIN;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CANCER INVASION; CANCER STAGING; CLINICAL FEATURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTIVARIATE ANALYSIS; PREOPERATIVE CARE; PRIORITY JOURNAL; PROGNOSIS; THROMBOCYTE COUNT; TUMOR GROWTH;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; ENDOTHELIAL GROWTH FACTORS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; LYMPHOKINES; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOVASCULARIZATION, PATHOLOGIC; PLATELET COUNT; PROSPECTIVE STUDIES; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0035132143     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000658-200102000-00012     Document Type: Article

References (50)

1. Endothelial cells and angiogenic growth factors in cancer growth and metastasis
2. Halting angiogenesis suppresses carcinoma cell invasion
3. Tumor angiogenesis: The pivotal role of vascular endothelial growth factor
4. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptor in adenocarcinomas of the gastrointestinal tract
5. Expression of vascular endothelial permeability factor (vascular endothelial growth factor) and its receptors in breast cancer
6. Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer
7. Vascular endothelial growth factor expression in primary esophageal squamous cell carcinoma: Association with angiogenesis and tumor progression
8. Expression of vascular permeability factor/vascular endothelial growth factor in human hepatocellular carcinoma
9. Clinical significance of vascular endothelial growth factor and basic fibroblast growth factor gene expression in liver tumor
10. Increased expression of vascular endothelial growth factor in human hepatocellular carcinoma
11. Vascular endothelial growth factor and platelet-derived growth factor are potential angiogenic and metastatic factors in human breast cancer
12. Prognostic Value of vascular endothelial growth factor expression in gastric carcinoma
13. Vascular endothelial growth factor expression in non-small-cell lung cancer: Prognostic significance in Squamous cell carcinoma
14. Expression of vascular endothelial growth factor in normal liver and hepatocellular carcinoma: An immunohistochemical study
15. Increased expression of vascular endothelial growth factor is associated with tumor progression in hepatocellular carcinoma
16. Significance of vascular endothelial growth factor mRNA expression in invasion and metastasis of hepatocellular carcinoma
17. Concentration of vascular endothelial growth factor in the sera of normal controls and cancer patients
18. Elevated levels of the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in sera of cancer patients
19. Serum vascular endothelial growth factor iS Often elevated in disseminated cancer
20. Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease
21. The predictive value of serum bFGF and VEGF in patients with metastatic renal cell carcinoma treated with interferon α-2b
22. Elevation Of serum level of vascular endothelial growth factor as new predictor of recurrence and disease progression in patients with superficial urothelial cancer
23. Vascular endothelial growth factor serum concentrations in ovarian cancer
24. High pre-treatment serum level of vascular endothelial growth factor (VEGF) is associated with poor outcome in small-cell lung cancer
25. A high pretreatment serum vascular endothelial growth factor concentration is associated with poor outcome in non-Hodgkin's lymphoma
26. Circulating vascular endothelial growth factor (VEGF) is a possible tumor marker for metastasis in human hepatocellular carcinoma
27. Primary carcinoma of the liver: A study of 100 among 48,900 necropsies
28. Prognostic significance of pathologic features of hepatocellular carcinoma. A multivariate analysis of 278 patients
29. Nonparametric estimation from incomplete observations
30. Incidence and factors associated with intrahepatic recurrence following resection of hepatocellular carcinoma
31. Recurrence of hepatocellular carcinoma after surgery
32. Intrahepatic recurrence after curative resection of hepatocellular carcinoma. Long-term results of treatment and prognostic factors
33. Factors affecting long-term outcome after hepatic resection for hepatocellular carcinoma
34. Hepatic resection versus transplantation for hepatocellular carcinoma
35. Is hepatocellular carcinoma in cirrhosis an actual indication for liver transplantation?
36. Liver transplantation for hepatocellular carcinoma: A registry report of the impact of tumor characteristics on outcome
37. Treatment of hepatocellular carcinoma associated with cirrhosis in the era of liver transplantation
38. Platelet number and interleukin-6 correlate with VEGF but not with bFGF serum levels of advanced cancer patients
39. Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets
40. Peripheral blood platelets express VEGF-C and VEGF which are released during platelet activation
41. Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: Significance for VEGF measurements and cancer biology
42. Constitutive expression of the thrombopoietin gene in a human hepatoma cell line
43. Factors correlated with portal venous invasion by hepatocellular carcinoma: Univariate and multivariate analyses of 232 resected cases without preoperative treatments
44. Significance of transcatheter chemoembolization combined with surgical resection for hepatocellular carcinomas
45. Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis
46. Preoperative chemoembolization of hepatocellular carcinoma: A comparative study
47. Lack of intrahepatic recurrence of hepatocellular carcinoma by temporary portal venous embolization with starch microspheres
48. Inhibitory effect of the angiogenesis inhibitor TNP-470 on tumor growth and metastasis in nude mice bearing human hepatocellular carcinoma
49. Serum vascular endothelial growth factor is a candidate biomarker of metastatic tumor response to ex vivo gene therapy of renal cell cancer